Clinical trial
Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma
NCT00003423 · United Kingdom Children's Cancer Study Group, Other · Unknown status
Key facts
| NCT number | NCT00003423 |
|---|---|
| Title | Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma |
| Official title | Non-Hodgkin's Lymphoma T Cell Protocol |
| Lead sponsor | United Kingdom Children's Cancer Study Group, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Drug |
| Interventions | asparaginase, cyclophosphamide, cytarabine, daunorubicin hydrochloride, dexamethasone, etoposide, mercaptopurine, methotrexate, prednisolone, thioguanine and 1 more |
| Enrollment | 100 |
| Start date | May 1, 1995 |
| First posted | May 20, 2004 |
| Last update posted | Dec 19, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: